<?xml version="1.0" encoding="UTF-8"?><!-- generator="WordPress/2.7" -->
<rss version="0.92">
<channel>
	<title>herpesisnormal.com</title>
	<link>http://herpesisnormal.com</link>
	<description></description>
	<lastBuildDate>Mon, 27 Jul 2009 16:08:50 +0000</lastBuildDate>
	<docs>http://backend.userland.com/rss092</docs>
	<language>en</language>
	
	<item>
		<title>Could Bavituximab mean a herpes cure?</title>
		<description>A few months ago we reported on a novel drug that might be an effective treatment or effective cure for herpes, a virus carried by the majority of adults. The drug was Bavituximab, a special protein that aids the immune system in recognising and treating virus-carrying cells.

In animals the drug ...</description>
		<link>http://herpesisnormal.com/?p=385</link>
			</item>
	<item>
		<title>Herpes sticker campaign launches</title>
		<description>

Herpesisnormal is campaigning for better awareness and understanding of herpes. Despite the fact that herpes is carried by most people, harmlessly and invisibly, there is still enormous fear and misunderstanding surrounding the condition. Many people think herpes is rare, but in fact the symptoms are rare, the virus is common.

Do ...</description>
		<link>http://herpesisnormal.com/?p=365</link>
			</item>
	<item>
		<title>Vical herpes vaccine is encouraging</title>
		<description>

Vical are reported to be making progress with their immunotherapeutic vaccine. An immunotherapeutic vaccine is one which provides immunity for those who do not carry herpes, as well as treatment for the majority of the population who already do.

One of the investigators, Dr David Koelle said, "We are encouraged that ...</description>
		<link>http://herpesisnormal.com/?p=356</link>
			</item>
	<item>
		<title>Knipe Lab herpes vaccine: An interview</title>
		<description>

Meet The Scientist has a fascinating interview with David Knipe of Harvard University. Knipe is developing a vaccine against HSV-2. 

Knipe discusses the challenges that researchers have faced in developing a vaccine against the virus, and explains why his new vaccine may be an answer. Knipe's vaccine has been shown ...</description>
		<link>http://herpesisnormal.com/?p=344</link>
			</item>
	<item>
		<title>Are we entering a golden age for antiviral drugs?</title>
		<description>Some herpes carriers will be familiar with drugs like acyclovir and Valtrex. Both are antiviral drugs based on the same chemical. Both are used to control herpes. But it may surprise you to learn the basic ingredients of acyclovir-based antivirals have remained unchanged for more than twenty years, and in ...</description>
		<link>http://herpesisnormal.com/?p=322</link>
			</item>
	<item>
		<title>Download, print, and mail your Oprah letter today!</title>
		<description>

Herpes carriers around the world are writing letters to Oprah, asking for a show dedicated to the common virus herpes simplex. Although herpes is carried by 50-90%+ of most populations, a much smaller number of people have any symptoms. These symptomatic people are often stigmatized, while the majority of people ...</description>
		<link>http://herpesisnormal.com/?p=274</link>
			</item>
	<item>
		<title>LA Times nominates herpes mouse &#8220;Rodent of the week&#8221;</title>
		<description>We've already covered this scientific development, but the LA Times take on it is worth a look. The story concerns the viral protein VP16, which scientists now think is produced before the herpes virus can leave the human nerve cell and cause any visible symptoms. If a drug can be ...</description>
		<link>http://herpesisnormal.com/?p=250</link>
			</item>
	<item>
		<title>Herpes forum starts Oprah letter-writing campaign</title>
		<description>Members of the herpes-coldsores forum plan to raise awareness of herpes research by writing letters to Oprah Winfrey, the influential American chat-show host. The forum members intend to persuade Oprah to devote a show to the common herpes-simplex virus known as HSV-1 and HSV-2. Together the viruses are carried by ...</description>
		<link>http://herpesisnormal.com/?p=241</link>
			</item>
	<item>
		<title>Target for herpes treatments discovered: VP16</title>
		<description>The herpes virus is carried by as many as 90% of people in most populations. The virus inserts itself into nerve structures in the human skin, where it stays for the entire lifetime of the carrier. Some people get regular coldsores, many people get just one, and the majority of ...</description>
		<link>http://herpesisnormal.com/?p=167</link>
			</item>
	<item>
		<title>Simplirix herpes vaccine should be available soon</title>
		<description>Although there's a mysterious quiet at Glaxo recently, the herpes vaccine Simplirix (formerly Herpevac) is finishing up Phase III trials. It won't be of any use to anyone who already has herpes, but it's the first real attempt to bring a vaccine to market. Current data suggests that the vaccine ...</description>
		<link>http://herpesisnormal.com/?p=207</link>
			</item>
</channel>
</rss>
